Novel oncolytic chimeric orthopoxvirus causes regression of pancreatic cancer xenografts and exhibits abscopal effect at a single low dose

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) has been increasing by 0.5% per year in the United States. PDAC portends a dismal prognosis and novel therapies are needed. This study describes the generation and characterization of a novel oncolytic chimeric orthopoxvirus for the treatment of pa...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Leary, Michael P., Choi, Audrey H., Kim, Sang-In, Chaurasiya, Shyambabu, Lu, Jianming, Park, Anthony K., Woo, Yanghee, Warner, Susanne G., Fong, Yuman, Chen, Nanhai G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918769/
https://www.ncbi.nlm.nih.gov/pubmed/29699566
http://dx.doi.org/10.1186/s12967-018-1483-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918769/
https://www.ncbi.nlm.nih.gov/pubmed/29699566
http://dx.doi.org/10.1186/s12967-018-1483-x

Ejemplares similares